Formulary e-News:

Having trouble viewing this email? View in a browser.

You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.

Subscribe Now

to Formulary e-News

Formulary, A peer-reviewed drug management journal for managed care and hospital decision-makers
Part of the Modern Medicine Network

e-News

FormularyJournal.com

March 18, 2011

Formulary
Home Medication Safety FDA Actions Latest News Policy Watch Drug Watch
In This Issue
Benefits, adverse effects influence elderly's adherence to cardiovascular meds
Limited literacy can mean low adherence
Anti-tumor necrosis factor-α effective in PsA
Resistance testing should guide initial HIV treatment choice

Survey

This month we would like to know...

Do you support The Preserving Access to Life-Saving Medicines Act, which would increase FDA's authority to prevent prescription drug shortages?

• Yes


• No

Click Here to Vote

Digital Edition

Formulary Digital Edition View Current Edition Subscribe to the Digital Edition

Both benefits and adverse effects influence elderly's adherence to cardiovascular medication

The willingness of the elderly to take medication for primary cardiovascular disease prevention is relatively insensitive to its benefit but highly sensitive to its adverse effects, according to a recent study published in the Archives of Internal Medicine. Read full article.

divider

Low literacy predicts nonadherence to medication regimens

Many patients, especially those with limited literacy, do not consolidate prescription medication regimens efficiently, which could lead to nonadherence, according to a recent study in the Archives of Internal Medicine. Read full article.

divider

Anti-tumor necrosis factor-α effective in psoriatic arthritis

Patients with psoriatic arthritis undergoing their first treatment with tumor necrosis factor-α inhibitor showed a high adherence to therapy and a good response, according to a recent Danish study published in Arthritis & Rheumatism. Read full article.

divider

Resistance testing should guide initial treatment choice in HIV

A substantial portion of antiretroviral-naïve patients are infected with transmitted drug-resistant HIV with one or more drug-resistant mutations, and they are much more likely to experience treatment failure, according to research published in The Lancet Infectious Diseases. Read full article.

divider

Top 5 Web Stories

  1. Dabigatran: A new orally available anticoagulant for prevention of strokes and thrombosis in patients with atrial fibrillation

  2. Contraceptive treatments: A review of current hormone options and newer agents for women

  3. Study finds different opioids offer variable safety in older adults with noncancer pain

  4. Dabigatran may be a cost-effective alternative to warfarin for stroke prevention in atrial fibrillation

  5. Risedronate sodium delayed-release tablets (Atelvia): A once-weekly oral bisphosphonate
divider

Contact Us

Contact a Formulary editor Click Here
Contact a Formulary sales representative Click Here
Learn about direct mail, reprints and classifieds in Formulary Click Here

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Healthcare

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.